Considerations in the design of preclinical safety evaluation programs for novel therapeutics used in neurologic diseases.

v1

Type:Journal Article

0 views

[![NobleID](https://www.nobleid.org/api/badge/24F816CD.svg?ark=w1%2F20260515%2F24F816CD&value=id)](https://nobleid.org/work/w1/20260515/24F816CD)

ARK Inflections

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors